Skip to main content

Table 1 Patient clinicopathological characteristics

From: Laparoscopy-assisted versus open D2 radical gastrectomy for advanced gastric cancer without serosal invasion: a case control study

Characteristics

LAG(n = 224)

OG(n) = 112

P- value

Sex:

  

0.778

Female (n)

175

89

 

Male (n)

49

23

 

Age(years, mean ± SD)

61.6 ± 10.6

60.8 ± 10.2

0.525

Tumor size(cm, mean ± SD)

4.7 ± 2.0

4.4 ± 2.0

0.631

Body mass index (kg/m2)

22.3

22.0

0.498

Tumor location (n):

  

0.083

Greater curvature

82

52

 

Lesser curvature

143

60

 

Gross type (n):

  

0.450

Elevated

50

21

 

Depressed

174

91

 

Histology (n):

  

0.875

Differentiated

37

17

 

Undifferentiated

187

95

 

ASA score (n):

  

0.857

 1

122

58

 

 2

94

49

 

 3

8

5

 

Comorbidities (n):

  

0.643

Presence of one or more comorbidities

102

54

 

Hypertension

43

16

 

Diabetes mellitus

17

10

 

Dyslipidemia

19

12

 

Cardiovascular

6

6

 

Pulmonary

8

5

 

Liver

5

3

 

Others

4

2

 

Tumor depth (n):

  

0.133

T2

81

50

 

T3

143

62

 

N stage (n):

  

0.681

N0

81

41

 

N1

42

25

 

N2

47

25

 

N3

54

21

 

TNM stage (n):

  

0.958

Ib

40

25

 

IIa

56

26

 

IIb

43

25

 

IIIa

41

20

 

IIIb

44

16

 

Resection extent (n):

  

1.000

TG

106

61

 

DG

118

51

 

Reconstruction (n):

  

0.058

BillrothI

101

37

 

BillrothII

16

14

 

Roux-y

107

61

 
  1. n, number of patients; ASA, American Society of Anesthesiologists; DG, distal gastrectomy; TG, total gastrectomy; TNM, tumor, node metastasis staging; LAG, laparoscopy-assisted gastrectomy; OG, open gastrectomy. P-values are for comparison of the LAG and OG groups.